Dynamics within the CD95 death-inducing signaling complex decide life and death of cells

This study explores the dilemma in cellular signaling that triggering of CD95 (Fas/APO‐1) in some situations results in cell death and in others leads to the activation of NF‐κB. We established an integrated kinetic mathematical model for CD95‐mediated apoptotic and NF‐κB signaling. Systematic model reduction resulted in a surprisingly simple model well approximating experimentally observed dynamics. The model postulates a new link between c‐FLIPL cleavage in the death‐inducing signaling complex (DISC) and the NF‐κB pathway. We validated experimentally that CD95 stimulation resulted in an interaction of p43‐FLIP with the IKK complex followed by its activation. Furthermore, we showed that the apoptotic and NF‐κB pathways diverge already at the DISC. Model and experimental analysis of DISC formation showed that a subtle balance of c‐FLIPL and procaspase‐8 determines life/death decisions in a nonlinear manner. We present an integrated model describing the complex dynamics of CD95‐mediated apoptosis and NF‐κB signaling.

[1]  J. Lippincott-Schwartz,et al.  Formation of stacked ER cisternae by low affinity protein interactions , 2003, The Journal of cell biology.

[2]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[3]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[4]  M. Peter,et al.  CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cells , 2004, The EMBO journal.

[5]  F. Allgöwer,et al.  Bistability Analyses of a Caspase Activation Model for Receptor-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[6]  M. Fussenegger,et al.  A mathematical model of caspase function in apoptosis , 2000, Nature Biotechnology.

[7]  J. Tschopp,et al.  cFLIP regulation of lymphocyte activation and development , 2006, Nature Reviews Immunology.

[8]  Nils Blüthgen,et al.  Mathematical Modeling Identifies Inhibitors of Apoptosis as Mediators of Positive Feedback and Bistability , 2006, PLoS Comput. Biol..

[9]  M. Butterworth,et al.  Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. , 2009, Molecular cell.

[10]  Andre Levchenko,et al.  Transient IkappaB kinase activity mediates temporal NF-kappaB dynamics in response to a wide range of tumor necrosis factor-alpha doses. , 2006, The Journal of biological chemistry.

[11]  M. Peter,et al.  Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.

[12]  K. Schulze-Osthoff,et al.  Many cuts to ruin: a comprehensive update of caspase substrates , 2003, Cell Death and Differentiation.

[13]  L. Hood,et al.  Activation of the NF-kappaB pathway by caspase 8 and its homologs. , 2000, Oncogene.

[14]  H. Shu,et al.  Activation of NF-kappaB by FADD, Casper, and caspase-8. , 2000, The Journal of biological chemistry.

[15]  P. Möller,et al.  Monoclonal antibody-mediated tumor regression by induction of apoptosis. , 1989, Science.

[16]  James E. Ferrell,et al.  A positive-feedback-based bistable ‘memory module’ that governs a cell fate decision , 2007, Nature.

[17]  J. Tschopp,et al.  The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex* , 2002, The Journal of Biological Chemistry.

[18]  Peter Scheurich,et al.  NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP , 2004, The Journal of cell biology.

[19]  A Krueger,et al.  The active caspase-8 heterotetramer is formed at the CD95 DISC , 2003, Cell Death and Differentiation.

[20]  J. Tschopp,et al.  The Caspase 8 Inhibitor c-FLIPL Modulates T-Cell Receptor-Induced Proliferation but Not Activation-Induced Cell Death of Lymphocytes , 2002, Molecular and Cellular Biology.

[21]  L. Hood,et al.  Activation of the NF-κB pathway by Caspase 8 and its homologs , 2000, Oncogene.

[22]  A. Weiss,et al.  Caspase-mediated Cleavage of Hematopoietic Progenitor Kinase 1 (HPK1) Converts an Activator of NFκB into an Inhibitor of NFκB* , 2001, The Journal of Biological Chemistry.

[23]  F. Martinon,et al.  The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways , 2000, Current Biology.

[24]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[25]  D. Lauffenburger,et al.  A Systems Model of Signaling Identifies a Molecular Basis Set for Cytokine-Induced Apoptosis , 2005, Science.

[26]  M. Peter,et al.  The CD95 Receptor: Apoptosis Revisited , 2007, Cell.

[27]  R. Eils,et al.  Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis , 2004, The Journal of cell biology.

[28]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[29]  You-Wen He,et al.  An essential role for c-FLIP in the efficient development of mature T lymphocytes , 2005, The Journal of experimental medicine.

[30]  Inna N Lavrik,et al.  Caspases: pharmacological manipulation of cell death. , 2005, The Journal of clinical investigation.

[31]  A. Weiss,et al.  Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFkappaB into an inhibitor of NFkappaB. , 2001, The Journal of biological chemistry.

[32]  P. Krammer,et al.  Cellular FLICE-inhibitory Protein Splice Variants Inhibit Different Steps of Caspase-8 Activation at the CD95 Death-inducing Signaling Complex* , 2001, The Journal of Biological Chemistry.

[33]  Andre Levchenko,et al.  Transient IκB Kinase Activity Mediates Temporal NF-κB Dynamics in Response to a Wide Range of Tumor Necrosis Factor-α Doses* , 2006, Journal of Biological Chemistry.

[34]  L. Salmena,et al.  Requirement for caspase-8 in NF-kappaB activation by antigen receptor. , 2005, Science.

[35]  G B Ermentrout,et al.  Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. , 2006, Biophysical journal.

[36]  P. Bastiaens,et al.  Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate , 2007, Nature Cell Biology.

[37]  Douglas A Lauffenburger,et al.  Effects of Bcl-2 Levels on Fas Signaling-Induced Caspase-3 Activation: Molecular Genetic Tests of Computational Model Predictions1 , 2005, The Journal of Immunology.

[38]  J. Tschopp,et al.  Cellular FLIP (Long Form) Regulates CD8+ T Cell Activation through Caspase-8-Dependent NF-κB Activation1 , 2005, The Journal of Immunology.

[39]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[40]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[41]  James R. Johnson,et al.  Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.

[42]  P. Krammer,et al.  The role of CAP3 in CD95 signaling: new insights into the mechanism of procaspase-8 activation , 2006, Cell Death and Differentiation.

[43]  C. Rauch,et al.  Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.

[44]  A. Hodgkin,et al.  A quantitative description of membrane current and its application to conduction and excitation in nerve , 1952, The Journal of physiology.

[45]  P. Krammer,et al.  c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[46]  Inna N. Lavrik,et al.  Life and death in peripheral T cells , 2007, Nature Reviews Immunology.

[47]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[48]  Roland Eils,et al.  Analysis of CD95 Threshold Signaling , 2007, Journal of Biological Chemistry.

[49]  A. Kerstan,et al.  NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2. , 2008, The Journal of investigative dermatology.

[50]  M. Peter,et al.  FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b* , 1997, The Journal of Biological Chemistry.

[51]  L. Salmena,et al.  Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor , 2005, Science.

[52]  Ravi S. Misra,et al.  Effector CD4+ T Cells Generate Intermediate Caspase Activity and Cleavage of Caspase-8 Substrates1 , 2005, The Journal of Immunology.

[53]  J. Tschopp,et al.  N-Terminal Fragment of c-FLIP(L) Processed by Caspase 8 Specifically Interacts with TRAF2 and Induces Activation of the NF-κB Signaling Pathway , 2004, Molecular and Cellular Biology.

[54]  M. Peter,et al.  Induction of apoptosis and activation of NF‐κB by CD95 require different signalling thresholds , 2004, EMBO reports.

[55]  D B Kell,et al.  Oscillations in NF-kappaB signaling control the dynamics of gene expression. , 2004, Science.

[56]  Xiaolu Yang,et al.  c‐FLIPL is a dual function regulator for caspase‐8 activation and CD95‐mediated apoptosis , 2002, The EMBO journal.

[57]  Ingo Schmitz,et al.  The Role of c-FLIP in Modulation of CD95-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[58]  A. Grosse-Wilde,et al.  Caspase‐10 is recruited to and activated at the native TRAIL and CD95 death‐inducing signalling complexes in a FADD‐dependent manner but can not functionally substitute caspase‐8 , 2002, The EMBO journal.

[59]  I. H. Engels,et al.  Caspase-2 Can Function Upstream of Bid Cleavage in the TRAIL Apoptosis Pathway* , 2004, Journal of Biological Chemistry.

[60]  Kwang-Hyun Cho,et al.  The influence of the signal dynamics of activated form of IKK on NF‐κB and anti‐apoptotic gene expressions: A systems biology approach , 2006, FEBS letters.

[61]  Michael Karin,et al.  NF-kappaB at the crossroads of life and death. , 2002, Nature immunology.

[62]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[63]  J. Ferrell,et al.  A positive-feedback-based bistable ‘memory module’ that governs a cell fate decision , 2003, Nature.

[64]  P. Krammer,et al.  The c-FLIP–NH2 terminus (p22-FLIP) induces NF-κB activation , 2006, The Journal of experimental medicine.

[65]  Jochen H M Prehn,et al.  Systems analysis of effector caspase activation and its control by X‐linked inhibitor of apoptosis protein , 2006, The EMBO journal.

[66]  Ning Sun,et al.  Genomic approaches in dissecting complex biological pathways. , 2004, Pharmacogenomics (London).